| Autor: |
Thomas S; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg simone.thomas@ukr.de., Schelker R; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Klobuch S; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Zaiss S; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Troppmann M; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Rehli M; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Herr W; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg., Reichle A; Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg. |
